Intrinsic Value of S&P & Nasdaq Contact Us

Moolec Science S.A. MLEC NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • LU • USD

SharesGrow Score
32/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.00
-59.5%

Moolec Science S.A. (MLEC) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is bullish — 1 Buy.

The consensus price target is $3.00, representing a downside of 59.5% from the current price $7.41.

Analysts estimate Earnings Per Share (EPS) of $-28.50 and revenue of $0.01B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-258.75 vs est $-28.50 (missed -807.9%). Analyst accuracy: 11%.

MLEC Stock — 12-Month Price Forecast

$3.00
▼ -59.51% Downside
Average Price Target
Based on 1 Wall Street analysts offering 12-month price targets for Moolec Science S.A., the price target is $3.00.
The average price target represents a -59.51% change from the last price of $7.41.

MLEC Analyst Ratings

Buy
1
Ratings
1 Buy
Based on 1 analysts giving stock ratings to Moolec Science S.A. in the past 3 months
Rating breakdown
Buy
1 100%
100%
Buy
1 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

EPS Estimates — MLEC

11%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual –$258.75 vs Est –$28.50 ▼ 89.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — MLEC

2%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual $0.334B vs Est $0.006B ▲ 98.3% off
Revenue Trend
Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message